Member Info for jdt1990

Welcome to the elite "green box filtered" club Robsaunders

Oh dear......LC sidetracked with Tanzania again. Come on LC, learn your lesson, finish one thing before you even contemplate another!
Gold = hot commodity now...get it over the line.
Nickel will be hot over the next couple of years with the EV revolution but i think I would pull my hair out if we saw another pointless MOU in Tanazia instead of Blyvoor funding done and dusted.

Someone is going to get burneeeddd adding to a SB short this close to some pretty transformational news (we hope - just for balance). I'd be running for the hills, especially if I had started it anywhere near the 200p+ peak.

That's taken directly from the article AVCT retweeted 13thmonkey. Agreed I was quite surprised at that price range!

https://blogs.jwatch.org/hiv-id-observations/index.php/rapid-inexpensive-home-testing-for-covid-19-may-get-us-out-of-this-mess-before-a-vaccine/2020/07/05/

Good find Bud_Fox. Interesting quote in there that gives an insight into potential pricing and also how key the S&S is to FDA approval:

Just shows how pivotal the optimisation process is to this product, all those out there shouting because its been "nearly 2 weeks". Rest assured they are working flat out to have this to the standard they need for FDA approval. LAst thing we need is a rushed, sub standard product to keep the rainbow chasing PI's happy that will need to go back to the drawing board....THEN THERE WILL BE DELAYS.

Coming out of this process with "best in class" reputation attached is just as important (if you are a LTH like most of us)

"Apparently, one thing that may be holding up FDA approval of these tests is that they are less sensitive than the PCR. That means they’re more likely than the PCR to miss someone who has COVID-19, wrongly giving a sense of reassurance from a false-negative result.

This is a legitimate concern, but one that should not block their urgent approval anyway. We should welcome these tests, even if less accurate, and broadly adopt them for widespread community use. Here’s why:

They will be cheap. Estimates are that they would cost between 1 and 5 dollars. That’s around the price of a cup of coffee.
They can be done on saliva. No brain biopsy required.
They can be done frequently. Every day for college students, or healthcare workers, or bus drivers? Every third day for everyone?
They will answer the key question — am I contagious to others right now?

Things have gone very quiet here....I’m hoping Emma does have some good news on permits and production very soon!

Pump before the inevitable dump?

AW - full of it, every day there will or won’t be an RNS and it will go up or down. Congrats on pointing out you “predicted” the right side of a 50/50 outcome. With those skills assume Warren Buffett is knocking on your door for your service!
How about you post something of substance? Idiot

From the last RNS.....”The Company expects to provide a further update to the market in respect of project level financing and associated timelines shortly after completion of the site visit referred to above.“

Not sure what he defines as shortly but nearly 2 weeks from the site visits this RNS needs to come soon!

In the previous Q&A AS also had a little giggle and we got an "Oh yes" when asked in the US Govt were aware of Avacta and our product....ducks could be lining here

Defintiely agree Daves1310. What I really like about today's RNS is that as you say, it highlights Affimers are clearly a multi purpose product. BUT also, some saying focus on the LFT, why are we venturing into other areas? People are missing the fact the optimisation of the LFT tests that CLEARLY WORK is with Cytiva. In the meantime, we are entreing into parterships where the companies have agreed to use AVCT as an integral part of a much wider product chain.
Would you commit to something like this knowing an integral part of your product may or may not be quite good enough to detect the virus. I dont think so!
This to me is another confidence booster saying these are going to be good, people are happy enough with the numbers to commit to using them in their workflows, so just wait to see how good they really are. "Gold Standard" we are being told is the aim

And you know this because.......
Just look at the volume of drilling they are doing, that's not being done for no reason.
You cant give any substantive reason for your "prediction" its all just hot air to fulfill whatever your agenda is.

RRR you are an utter numpty....the share price rise is based on 8 consistently outstanding sets of drill results, what makes you think this is heading to 7/8p? I'd love to know, and if you give an answer with some substance, id be open to hearing it.
But lets be honest - you either want a lower entry or your short isn't working out. Jog on

Thanks for your input there jag but after your view that " you just need an a4 piece of paper which picks up covid slap it in the sewage works and if it turns a certain color BINGO!" I think i'll leave the science to AS and his team and probably overlook your very well informed view that "saliva tests don't pick up covid or nowhere near enough to warrant use."
Muppet

If only generating these products was as simple as you jag189.....

Cristalball - I know you’re a regular deramper here but I’ll give you the courtesy of a response...what would be more painful is Avct rushing a sub standard product to market and permanently tarnishing the reputation of the business before they have even started the key stages in their core cancer business

Try again Jimbooo....busted you deramping AVCT over on the NCYT board!

RE: Airline/Airport Testing08 Jul 2020 11:20
Holy hell! Might as well sell my avacta holding, they're not just missing the boat, they're missing the entire holiday. What a pump and dump that stock is turning out to be

Don’t come over here saying this is a saturated market and trying to ramp NCYT. They’re the ones in a saturated market. Can you name me our saliva based LFT tests looking FM to provide on the spot results in 10 mins?

The placing was an opportunistic move and I have no issue with it. To do a placing of that size at 4% discount on AIM, with a solid hedge fund in the mix, what’s rotten about that?
Either you didn’t get any placing shares at 120 or you are bitter because you got spiked.
They raised to progress shelved projects in their core business area and this COViD play is simply an opportunity to prove up affimers and generate some near term revenue.
Of course you know all this....just your usual deramping rubbish

How do you know they are focusing on everything but the LFT. Could well be that while the optimisation is taking place, given they have done the leg work with the product, Avacta are out looking for additional revenue streams....shrewd.
Why would they not be pushing to have the best test out there, it just takes time and given no direct competition (apart from derampers like you saying delay delay panic panic!!) and COViD going nowhere they have that time.
Anyway....last response you’ll get from me. Wind up merchant

You keep trying to tell people AW but nobody listens as you’re a tiresome deramper up to you usual tricks. Go hassle some other bb or add some value here